Furthermore, in genetically engineered lung cancer mice an mTOR inhibitor combined with a PD-1 antibody decreased tumor growth, increased tumor-infiltrating T cells, and decreased regulatory T cells [89]. This evidence concerns the gene MTOR and lung carcinoma.